{"id":32562,"date":"2025-04-28T11:01:19","date_gmt":"2025-04-28T03:01:19","guid":{"rendered":"https:\/\/flcube.com\/?p=32562"},"modified":"2025-04-28T11:01:20","modified_gmt":"2025-04-28T03:01:20","slug":"roches-q1-2025-results-pharma-sales-drive-8-growth-amidst-flat-diagnostics","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=32562","title":{"rendered":"Roche&#8217;s Q1 2025 Results: Pharma Sales Drive 8% Growth Amidst Flat Diagnostics"},"content":{"rendered":"\n<p>Swiss pharmaceutical giant Roche (<a href=\"https:\/\/www.google.com\/finance\/quote\/ROG:SWX\">SWX: ROG<\/a>, <a href=\"https:\/\/www.google.com\/finance\/quote\/RHHBY:OTCMKTS\">OTCMKTS: RHHBY<\/a>) reported Q1 2025 financials with global group revenues increasing by 6% year-on-year in constant currency terms to CHF 15.44 billion (USD 18.64 billion). Within that, pharma group sales grew by 8% YOY to CHF 11.95 billion (USD 14.43 billion), while diagnostics sales remained flat at 0% growth at CHF 3.49 billion (USD 4.21 billion).<\/p>\n\n\n\n<p><strong>Pharma Division Highlights<\/strong><br>The pharma division\u2019s key growth drivers were identified as breast cancer drug Phesgo (pertuzumab\/trastuzumab\/hyaluronidase), ophthalmology drug Vabysmo (faricimab), allergy and asthma therapy Xolair (omalizumab), hemophilia drug Hemlibra (emicizumab), and influenza drug Xofluza (baloxavir marboxil). Together, they contributed CHF 3.6 billion (USD 4.3 billion) in sales, an increase of CHF 0.7 billion (USD 845 million) from the same quarter in 2024.<\/p>\n\n\n\n<p><strong>Regional Performance<\/strong><br>Pharmaceutical sales increased across major regions. In the United States, sales were up 6% YOY to CHF 6.22 billion (USD 7.5 billion). Europe saw a 5% increase to CHF 2.32 billion (USD 2.8 billion). Japan reported a 3% rise to CHF 671 million (USD 810 million). International markets, including China, saw the most significant growth at 18%, reaching CHF 2.73 billion (USD 3.3 billion). China alone contributed 14% to the international sales growth, driven by demand for Xofluza and Phesgo.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/irp250424-a.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of irp250424-a.\"><\/object><a id=\"wp-block-file--media-25c26ed2-6b9c-4e1f-8ae2-ebf910c9a8e6\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/irp250424-a.pdf\">irp250424-a<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/irp250424-a.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-25c26ed2-6b9c-4e1f-8ae2-ebf910c9a8e6\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Swiss pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) reported Q1 2025 financials with global group&#8230;<\/p>\n","protected":false},"author":1,"featured_media":32564,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[940,939],"class_list":["post-32562","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-otcmkts-rhhby","tag-swx-rop"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Roche&#039;s Q1 2025 Results: Pharma Sales Drive 8% Growth Amidst Flat Diagnostics - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Swiss pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) reported Q1 2025 financials with global group revenues increasing by 6% year-on-year in constant currency terms to CHF 15.44 billion (USD 18.64 billion). Within that, pharma group sales grew by 8% YOY to CHF 11.95 billion (USD 14.43 billion), while diagnostics sales remained flat at 0% growth at CHF 3.49 billion (USD 4.21 billion).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=32562\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Roche&#039;s Q1 2025 Results: Pharma Sales Drive 8% Growth Amidst Flat Diagnostics\" \/>\n<meta property=\"og:description\" content=\"Swiss pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) reported Q1 2025 financials with global group revenues increasing by 6% year-on-year in constant currency terms to CHF 15.44 billion (USD 18.64 billion). Within that, pharma group sales grew by 8% YOY to CHF 11.95 billion (USD 14.43 billion), while diagnostics sales remained flat at 0% growth at CHF 3.49 billion (USD 4.21 billion).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=32562\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-28T03:01:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-28T03:01:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2802.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32562#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32562\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Roche&#8217;s Q1 2025 Results: Pharma Sales Drive 8% Growth Amidst Flat Diagnostics\",\"datePublished\":\"2025-04-28T03:01:19+00:00\",\"dateModified\":\"2025-04-28T03:01:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32562\"},\"wordCount\":200,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32562#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/2802.webp\",\"keywords\":[\"OTCMKTS: RHHBY\",\"SWX: ROP\"],\"articleSection\":[\"Others\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=32562#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32562\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=32562\",\"name\":\"Roche's Q1 2025 Results: Pharma Sales Drive 8% Growth Amidst Flat Diagnostics - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32562#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32562#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/2802.webp\",\"datePublished\":\"2025-04-28T03:01:19+00:00\",\"dateModified\":\"2025-04-28T03:01:20+00:00\",\"description\":\"Swiss pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) reported Q1 2025 financials with global group revenues increasing by 6% year-on-year in constant currency terms to CHF 15.44 billion (USD 18.64 billion). Within that, pharma group sales grew by 8% YOY to CHF 11.95 billion (USD 14.43 billion), while diagnostics sales remained flat at 0% growth at CHF 3.49 billion (USD 4.21 billion).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32562#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=32562\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32562#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/2802.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/2802.webp\",\"width\":1080,\"height\":608,\"caption\":\"Roche's Q1 2025 Results: Pharma Sales Drive 8% Growth Amidst Flat Diagnostics\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=32562#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Roche&#8217;s Q1 2025 Results: Pharma Sales Drive 8% Growth Amidst Flat Diagnostics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Roche's Q1 2025 Results: Pharma Sales Drive 8% Growth Amidst Flat Diagnostics - Insight, China&#039;s Pharmaceutical Industry","description":"Swiss pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) reported Q1 2025 financials with global group revenues increasing by 6% year-on-year in constant currency terms to CHF 15.44 billion (USD 18.64 billion). Within that, pharma group sales grew by 8% YOY to CHF 11.95 billion (USD 14.43 billion), while diagnostics sales remained flat at 0% growth at CHF 3.49 billion (USD 4.21 billion).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=32562","og_locale":"en_US","og_type":"article","og_title":"Roche's Q1 2025 Results: Pharma Sales Drive 8% Growth Amidst Flat Diagnostics","og_description":"Swiss pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) reported Q1 2025 financials with global group revenues increasing by 6% year-on-year in constant currency terms to CHF 15.44 billion (USD 18.64 billion). Within that, pharma group sales grew by 8% YOY to CHF 11.95 billion (USD 14.43 billion), while diagnostics sales remained flat at 0% growth at CHF 3.49 billion (USD 4.21 billion).","og_url":"https:\/\/flcube.com\/?p=32562","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-04-28T03:01:19+00:00","article_modified_time":"2025-04-28T03:01:20+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2802.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=32562#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=32562"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Roche&#8217;s Q1 2025 Results: Pharma Sales Drive 8% Growth Amidst Flat Diagnostics","datePublished":"2025-04-28T03:01:19+00:00","dateModified":"2025-04-28T03:01:20+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=32562"},"wordCount":200,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=32562#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2802.webp","keywords":["OTCMKTS: RHHBY","SWX: ROP"],"articleSection":["Others"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=32562#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=32562","url":"https:\/\/flcube.com\/?p=32562","name":"Roche's Q1 2025 Results: Pharma Sales Drive 8% Growth Amidst Flat Diagnostics - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=32562#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=32562#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2802.webp","datePublished":"2025-04-28T03:01:19+00:00","dateModified":"2025-04-28T03:01:20+00:00","description":"Swiss pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) reported Q1 2025 financials with global group revenues increasing by 6% year-on-year in constant currency terms to CHF 15.44 billion (USD 18.64 billion). Within that, pharma group sales grew by 8% YOY to CHF 11.95 billion (USD 14.43 billion), while diagnostics sales remained flat at 0% growth at CHF 3.49 billion (USD 4.21 billion).","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=32562#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=32562"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=32562#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2802.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2802.webp","width":1080,"height":608,"caption":"Roche's Q1 2025 Results: Pharma Sales Drive 8% Growth Amidst Flat Diagnostics"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=32562#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Roche&#8217;s Q1 2025 Results: Pharma Sales Drive 8% Growth Amidst Flat Diagnostics"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/2802.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/32562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=32562"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/32562\/revisions"}],"predecessor-version":[{"id":32565,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/32562\/revisions\/32565"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/32564"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=32562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=32562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=32562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}